IL11, interleukin 11, 3589

N. diseases: 244; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Multiple Sclerosis, Relapsing-Remitting
0.020 Biomarker disease BEFREE These results suggest that IL-11 might serve as a biomarker of early autoimmune response and a selective therapeutic target for patients with early relapsing-remitting MS. 31341075 2019
Multiple Sclerosis, Relapsing-Remitting
0.020 Biomarker disease BEFREE We conclude that by suppressing Th17 cell-mediated neuroinflammation and demyelination, IL-11 antagonist can be further studied as a potential selective and early therapy for RRMS. 30149119 2018